A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This trial is conducted in Europe. The aim of this trial is to evaluate the blood glucose-lowering effect of NN5401 (insulin degludec/insulin aspart (IDegAsp)) in subjects with type 2 diabetes.
Epistemonikos ID: 14c1c80c66d176eff92c9f9a1fb09ecb3aa6948c
First added on: May 05, 2024